Skin lipid receptors may trigger internal signals that reduce damage in distant tissues

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

Nothing is known here: the question has not been asked of this system.

Which repair action slows damage across human tissues beyond reducing energy demand, and which comparison explains its effect?

The engine's own statement of the hypothesis, in full.

SCOUT from cutaneous pharmacology and lipid receptor biology, conditional: In a prospectively defined subset of aging humans, a topical lipid L may activate a receptor R in a defined viable skin-cell population, alter a receptor-regulated endogenous mediator K and thereby reduce formation of a specified remote damage class independently of equivalent physical barrier restoration. L, R, K, the responding cells and the remote damage class remain unresolved identities. The frozen unexpected consequence is retained as a separate strict comparative hypothesis: under a specified population, exposure, maintenance regime and post-transient interval, receptor-active formulation A has a lower deterioration slope than a defined metabolic-demand-reduction comparator M, while barrier-equivalent receptor-inactive formulation B does not: b_A<b_M and b_B≥b_M. Practical effect-margin hypotheses are distinct and cannot substitute for this ordering. Receptor dependence alone entails neither version. Physical barrier repair, lysosomal repair, efferocytosis restoration and metabolic-demand reduction may provide compatible or interacting benefits. The proposed endogenous-mediator pathway must be distinguished from direct remote action of formulation constituents and metabolites, including receptor-regulated production or transport of active metabolites in skin. If sustained endogenous signaling reduces remote damage formation while preserving function, it could improve corresponding SPV_1 components. Neither the pathway, strict ordering, practical magnitude nor whole-human benefit is established.

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

• Rival 01 of 03

  Macrophage ingestion of recoverable cells may dominate ongoing functional-cell loss

  Not yet published.

  What would separate them

  Macrophage ingestion of recoverable cells may dominate ongoing functional-cell loss predicts: Begin with donor-matched older-human skin tissue–macrophage cultures, specifying target-cell identity, anatomical site, macrophage state, chronological age, sex, diseases and medications. Skin is the proposed first system, not an established dominant tissue. First establish a physiologically justified reversible-stress range and a reproducible target population capable of sustained tissue-relevant recovery. Define the recovery endpoint and observation interval before confirmatory testing, including delayed death; do not identify a human responder subgroup solely from a favorable intervention outcome. Use low macrophage densities at which direct observation finds no material interference. Cross selective TIM-4 restoration, target-cell-restricted lysosomal repair and selective ingestion prevention with vehicle and pathway controls. Use two mechanistically distinct ingestion perturbations where feasible, but establish their selectivity rather than assuming it. Validate precontact fate indicators in randomized matched protected cohorts; the same ingested cell's counterfactual recovery cannot be observed. Measure attachment, completed internalization and ingestion-attributable irreversible loss separately. Quantify primary and delayed irreversible death, genuine corpse production, extracellular residence, uptake, intracellular retention and destruction, together with inflammation, repair and durable tissue function. Measure cell replacement, lineage contribution where feasible and functional compensation so that preserved cell number is not equated with preserved tissue performance. Define dominance prospectively over a specified population and interval, for example as more than half of gross continuing functional-cell loss attributable to ingestion; this is an operational proposal, not an observed biological threshold. Report that attribution separately from net functional loss and account for interacting causes rather than summing overlapping losses. The focal prediction is a TIM-4-restoration-by-ingestion interaction: increased attachment produces additional irreversible loss from the validated recoverable population when ingestion is permitted, and selective prevention preserves durable function. The stronger frozen consequence additionally requires fewer genuine extracellular corpses and worse net tissue preservation, with ingestion-related functional costs exceeding beneficial clearance, including delayed inflammation and repair. Target-only, conditioned-medium and secretion measurements must test whether apparent protection instead follows reduced initial injury or altered macrophage output. Comparable genuine corpse clearance must be verified during selective target protection; protection does not itself predict more corpses. Test the contextual p38–TIM-4 link separately through p38 activity, TIM-4 surface abundance, attachment and internalization, with selective perturbation and TIM-4 interruption or rescue. MerTK effects cannot establish this link. For the repair explanation, demonstrate target-cell lysosomal injury, the proposed recognition or recovery state, compartment-restricted repair and restoration before irreversible commitment; follow membrane integrity, leakage, acidity, recognition signals and function. Exclude macrophage exposure and independently altered macrophage processing. A repair benefit remaining when ingestion is prevented can support primary-injury prevention or another compatible route. Match initial stress, oxygen, nutrients and measured metabolic flux where feasible. Observe contact over hours and recovery over days, extending repeated exposure only within demonstrated culture viability; these are proposed windows, not adequate chronic-human follow-up. Failure to find recoverable targets, ingestion-caused death, TIM-4 dependence, quantitative dominance or net harm constrains the corresponding claim under the adequately perturbed conditions. Net benefit from attachment restoration can coexist with a smaller harmful ingestion pathway. Subsequently compare post-transient damage and functional trajectories with attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls.

• Rival 02 of 03

  Macrophage obstruction may slow corpse clearance and sustain tissue injury
  What would separate them

  Macrophage obstruction may slow corpse clearance and sustain tissue injury predicts: Use older-human donor macrophages in a defined three-dimensional dermal system with verified irreversibly dead targets of specified identity and size. Record donor age, sex, diseases, medications and macrophage state. First measure relevant human-tissue density ranges and spatial distributions. Independently vary N and M, separating fixed-N and fixed-N/M paths. Directly image contacts that interrupt encounter, capture, internalization or subsequent processing; quantify their duration, recurrence and attributable lost clearance time. Mere contact at high density is insufficient. Measure accessible volume, target depletion and accessibility, motility, encounter frequency, capture probability, oxygen, nutrients, viability, activation, metabolic flux, intracellular processing and readiness for another target. Cross calibrated attachment enhancement with selective relief of the observed interruption. At the same N and M, interference relief should recover consequential lost clearance time and increase completed destruction beyond changes explained by ordinary access, resources, capture or intrinsic handling. Relief of the obstruction itself may improve access; distinguish that causal change from unrelated changes in baseline accessibility rather than requiring access to remain invariant by definition. Use reversible or orthogonal perturbations where feasible and verify their specificity. Define a completed-removal event for the chosen target using observed uptake and processing of specified material; separately report any residual refractory fraction. Calibrate q and r independently and prospectively compare the two interventions below and above the crossover when c>0 and qr<1. Compare per-cell and total clearance within each density. Continued benefit from attachment enhancement, a positive fitted c or a throughput crossover alone does not prove direct interference. If qr≥1, the stated pure-parameter interventions have no crossover. If interventions also alter h, geometry, access or cell state, use measured changes to test the full response rather than applying the simple threshold. Validate predictions on held-out density combinations and during serial processing; allow rejection of constant parameters or the quasi-steady approximation. Observe contacts over hours and processing over days within demonstrated culture viability. Measure corpse production, extracellular residence, uptake, intracellular stock, export and destruction products separately. Faster uptake may increase storage, and faster destruction may leave an injury process unchanged. After a selective clearance rescue, test secondary injury, tissue function and post-transient damage slopes directly against attachment restoration, compartment-specific lysosomal repair, measured metabolic-demand reduction and appropriate controls. Failure of selective rescue at relevant densities challenges direct interference in that regime; failure of the crossover constrains the comparative prediction without excluding interference generally. Failure to reduce injury despite increased destruction limits the downstream aging claim.

• Rival 03 of 03

  Altered protein chemistry may block breakdown until chemical repair enables disposal
  What would separate them

  Altered protein chemistry may block breakdown until chemical repair enables disposal predicts: Begin with sequence-matched modified, unmodified and pre-corrected proteins with analytically resolved modification sites, linkage and stereoisomers. Use standards and sample-handling controls to distinguish biological modification from changes introduced during preparation. In defined proteolytic conditions, compare direct effects with conformation, aggregation and accessibility held comparable; separately measure total effects when modification is allowed to change folding or aggregation, since these can mediate chemical resistance. Measure modification formation and backbone turnover independently to distinguish modification-driven retention from residence-driven modification. Identify a matching endogenous pool at functionally consequential abundance in older-human donor cells, initially proposed dermal fibroblasts, recording age, sex, disease and treatment. Define consequential abundance through a measurable effect on specified tissue-relevant function at endogenous exposure rather than merely enrichment in old material. Specify whether the pool is cytosolic, lysosomal, extracellular-matrix-associated or corpse-associated. Cross verified lysosomal integrity, leakage, acidity, delivery and ordinary proteolytic capacity with active versus catalytically inactive repair enzyme at comparable delivery, localization, substrate access and cofactor exposure. Avoid artificial overload and independent toxicity; measure metabolic flux, synthesis and stress responses. The focal result is selective persistence of the modified pool despite restored ordinary processing, followed by verified chemical correction that causally increases destruction of the same labeled backbone. Establish the correction-mediated step using analytically characterized pre-corrected substrate: remove the repair enzyme and reaction components before a matched degradation challenge, with sham-treated modified controls, so a direct effect of the enzyme or carryover on proteases cannot alone explain rescue. Confirm the relevant result in endogenous material; cell-free rescue does not establish cellular delivery. Measure correction yield, remaining modified forms and the accessible repairable fraction. Track intact modified and corrected backbones, degradation products, export, cell loss, redistribution, new synthesis and label recycling across original cells, macrophages and medium. Loss of an isomer signal, catalytic dependence or temporal order alone is insufficient. For the uptake prediction, directly trace the same identified modified backbone from corpse cargo into macrophages, verify restored ordinary macrophage processing, and test persistent material and correction-enabled destruction within that compartment. Fibroblast retention and cell-free resistance do not establish macrophage resistance. If the pool never reaches macrophages, investigate access and trafficking. Observe chemical conversion over hours and turnover over days or longer within demonstrated viability. Comparable degradation after ordinary processing restoration weakens the proposed chemical limitation for that substrate. Correction that improves function without increasing backbone destruction supports a compatible direct-repair interpretation rather than the parent degradation chain. Only after establishing the causal sequence should repeated exposure compare post-transient accumulation, functional injury and harms with membrane repair, uptake restoration and measured metabolic-demand reduction.

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.